Shimon Sakaguchi
| Shimon Sakaguchi 坂口 志文 | |
|---|---|
| Lahir | 19 Januari 1951 Prefektur Shiga, Jepang |
| Pendidikan | Universitas Kyoto MD (1976) Ph.D (1982) |
| Dikenal atas | Regulatory T cells |
| Penghargaan | William B. Coley Award (2004) Crafoord Prize (2017) Robert Koch Prize (2020) Penghargaan Nobel Fisiologi atau Kedokteran (2025) |
| Karier ilmiah | |
| Bidang | Patologi, imunologi |
| Institusi | Universitas Johns Hopkins Universitas Stanford Scripps Research Institute RIKEN Universitas Tokyo Universitas Osaka |
Shimon Sakaguchi (坂口 志文, Sakaguchi Shimon, lahir 19 Januari 1951) adalah seorang imunologis dan Distinguished Professor Universitas Osaka.[1] Ia dikenal atas penemuan sel T regulator dan menjelaskan perannya dalam sistem imun. Penemuan tersebut dipakai dalam pengobatan kanker dan penyakit autoimun. Sakaguchi meraih Penghargaan Nobel Fisiologi atau Kedokteran pada 2025.
Referensi
- ^ "Experimental Immunology – Osaka University Immunology Frontier Research Center". IFReC | Osaka University Immunology Frontier Research Center. Diakses tanggal 1 May 2021.
Pranala luar
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.